SCHEMBL24105695

SCHEMBL24105695

CONC(C)c1ccccc1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.48
SOS1 Q07889 1/20 0.41
SLC6A4 P31645 3/20 0.40
SLC6A2 P23975 2/20 0.40
SLC6A3 Q01959 2/20 0.40
ADRB2 P07550 1/20 0.40
ACHE P22303 2/20 0.36
TSHR P16473 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
ADRA2A P08913 2/20 0.36
ADRA2B P18089 2/20 0.36
ADRA2C P18825 1/20 0.36
HTR2A P28223 2/20 0.35
CYP2D6 P10635 3/20 0.34
ALDH1A1 P00352 2/20 0.34
ACP3 P15309 1/20 0.34
SLC22A2 O15244 1/20 0.33
SLC22A1 O15245 1/20 0.33
GRIN2D O15399 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8649226 0.78 ESR1 (0.50) ESR1SOS1SLC6A4SLC6A2SLC6A3
SCHEMBL2402249 0.76 SLC6A4 (0.50) ESR1SOS1SLC6A4SLC6A2SLC6A3
SCHEMBL15247632 0.76 ESR1 (0.48) ESR1SOS1SLC6A4SLC6A2SLC6A3
SCHEMBL15325823 0.74 ALDH1A1 (0.63) SOS1ALDH1A1CYP2C19
SCHEMBL6114378 0.74 ESR1 (0.46) ESR1SOS1SLC6A4SLC6A2SLC6A3
SCHEMBL28879943 0.74 ESR1 (0.46) ESR1SOS1SLC6A4SLC6A2SLC6A3
SCHEMBL9055270 0.71 ALDH1A1 (0.55) SLC6A4SLC6A2SLC6A3ADRA2ACYP2D6
SCHEMBL28682070 0.71 ESR1 (0.54) ESR1SOS1SLC6A4SLC6A2SLC6A3
SCHEMBL15854157 0.71 ESR1 (0.54) ESR1SOS1SLC6A4SLC6A2SLC6A3
SCHEMBL29061018 0.71 ESR1 (0.54) ESR1SLC6A4SLC6A2SLC6A3ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3877394-B1 HYDROGENATION PROCESS OF OXIME DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2024-06-26 EP disclosed
US-20210387173-A1 HYDROGENATION PROCESS OF OXIME DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2021-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387173-A1 HYDROGENATION PROCESS OF OXIME DERIVATIVES HMOX2, HAO2, PRDX5 ESR1 3156/4885SOS1 2594/4885SLC6A4 3242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.